FDA Commissioner Scott Gottlieb offered an update on the agency’s plans to address the opioid epidemic, encourage market competition, and tackle internal agency issues, in remarks Tuesday to the Alliance for a Stronger FDA in Washington, D.C.
Source: Drug Industry Daily